SavedAdd your journal

Journals / İnönü Üniversitesi Tıp Fakültesi Dergisi / 2010 / Cilt: 17 - Sayı: 3

Obstrüktif sleep apneli obez ve obez olmayan hastalarda serum neopterin seviyeleri

Serum neopterin levels in obese and non-obese patients with obstructive sleep apnea syndroms

Nadir KOÇAK
Recep KESLİ
Taha T. BEKÇİ
Pages
165–168
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In this study, no significant difference was found in terms of NP levels between non-obese and obese OSAS patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Obstructive sleep apnea syndrome (OSAS) is one of the most common sleep breathing disorder characterized by nocturnal oxygen desaturation and repeated upper airway obstruction episodes during sleep.
📊
Key Findings & Data:Methods: Twenty non-obese OSAS, 15 obese OSAS were enrolled into this study.
💡
Conclusion & Impact:Conclusion: In this study, no significant difference was found in terms of NP levels between non-obese and obese OSAS patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Obstructive sleep apnea syndrome (OSAS) is one of the most common sleep breathing disorder characterized by nocturnal oxygen desaturation and repeated upper airway obstruction episodes during sleep. Neopterin (NP), as an immune modulator, is secreted by macrophages activated by T-lymphocytes. In the light of literature, higher serum NP levels are reported to be encountered in obese subjects. While this marker was used in obese OSAS subjects, no data related to this marker to be used in non-obese OSAS subjects could be encountered in previous studies. In this study, it was aimed to compare serum NP levels in non-obese with obese OSAS subjects. Methods: Twenty non-obese OSAS, 15 obese OSAS were enrolled into this study. Diagnostic polysomnography (PSG) was performed in all patients during all night sleep. Sleep stages and respiratory events were manually scored. Serum NP levels of obese OSAS subjects were compared with non-obese OSAS subjects . Results: Serum neopterin levels were 5.25±0.43 ng/ml in obese and 5.17±0.52 ng/ml in non-obese OSAS patients (p > 0.05). Conclusion: In this study, no significant difference was found in terms of NP levels between non-obese and obese OSAS patients.

Özet

Amaç: Obstruktif sleep apne sendromu (OSAS) uyku oksijen saturasyonun bozulması ve uyku sırasında tekrarlayan üst hava yolu obstruksiyonu epizodları ile karakterize en yaygın uyku solunum bozukluğudur. Bir immünomodülatör olan neopterin (NP) T lenfositler tarafından aktive edilen makrofajlar tarafından salgılanmaktadır. Literatür ışığında, yüksek serum NP seviyelerinin obes kişilerde rastlandığı rapor edilmiştir. Bu marker obez OSAS’lı kişilerde kullanılırken, obez olmayan OSAS’lı kişilerde bu markerin kullanıldığıyla ilişkili bilgilere önceki çalışmalarda rastlanılmadı. Bu çalışmada biz, obez OSAS’lı kişilerle obez olmayan OSAS’lı kişiler arasında serum NP seviyelerini karşılaştırmayı amaçladık. Metod: Bu çalışmaya 20 obez olmayan ve 15 obez OSAS’lı hasta dahil edildi. Hastalara bir gece boyunca diagnostik polisomnografi (PGS) uygulandı. Uyku süreçleri ve respiratuar durumlar manuel olarak skorlandı. Obez OSAS’lıların serum NP düzeyleri non-obez OSAS’lılarla karşılaştırıldı. Bulgular: Serum neopterin seviyeleri obez OSAS’lılarda 5.25±0.43 ng/ml, obez olmayan OSAS’lılarda 5.17±0.52 ng/ml olarak bulundu (p > 0.05). Sonuç: Bu çalışmada, obez ve obes olmayan OSAS’lı hastalar arasında NP seviyeleri açısından önemli bir farklılık bulunamamıştır.

🔖

Cite This Article

KOÇAK, N., KESLİ, R., BEKÇİ, T. T. (2022). Obstrüktif sleep apneli obez ve obez olmayan hastalarda serum neopterin seviyeleri. İnönü Üniversitesi Tıp Fakültesi Dergisi, Cilt: 17 - Sayı: 3, 165–168. https://ajindex.com/articles/546611

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Phillipson EA. Sleep apnea, in Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds): Harrison’s Principles of Internal Medicine, 15th ed. New York, McGraw- Hill 2001; 1520-3
  2. Partinen M, Jamieson A, Guilleminault C. Long–term outcome for obstructive sleep apnea syndrome patients: mortality. Chest 1988; 94:1200-4
  3. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84
  4. Shepard JW. Hypertansion, cardiac arrytmias, myocardial infarction, and stroke in relation to obsructive sleep apnea. Clin Chest Med 1992; 13:437-58
  5. Wolk R, Kara T, Somers VK. Sleep–disorderd breathing and cardiovasculer diseases. Circulation 2003; 108: 9-12
  6. Silverberg DS, Oksenberg A. Are sleep related breathing disorders important contributing factors to the production of essential hypertansion? Curr Hypertens Rep 2001; 3: 209-15
  7. Zwillich C, Sinoway L. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 1995; 79: 581-88
  8. Jelic S, Bartels MN, Mateika JH, Ngai P, DeMeersman RE, Basner RC. Arterial stiffness increases during obstructive sleep apneas. Sleep 2002; 25: 15-20
  9. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Schmidt K, Weiss G, Wachter H. Pteridine biosynthesis in human endothelial cells: Impact on nitric oxidemediated formation of cyclic GMP. J Biol Chem 1993; 268: 1842-6
  10. Punjabi NM, Beamer BA, Jain A, Spencer ME, Fedarko N. Elevated levels of neopterin in sleep-disordered breathing. Chest 2007;132:1124-30
  11. Ursavaş A, Karadag M, Oral AY, Demirdogen E, Oral HB, Ege E. Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea. Respir Med 2008;102:1193-7
  12. Ledochowski M, Murr C, Widner B, Fuchs D. Association between insulin resistance, body mass and neopterin concentrations. Clin Chim Acta 1999;282:115-23
  13. Thorpy M, Committee ftDCS. The International Classification of Sleep Disorders: Diagnostic and Coding Manuel. Rochester MN, American Sleep Disorders Association, 1990 14. Tracy RP. Is visceral adiposity the enemy within? Arterioscler Thromb Vasc Biol 2001; 21: 881-3
  14. Kern PA, Saghizadeh M, Ong JM, Bosh RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95